# FDA Approves Merck's WINREVAIR (sotatercept-csrk), Expanding Treatment Options in Pulmonary Hypertension Market Merck Sharp & Dohme LLC's FDA appro...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Idorsia Pharmaceuticals Ltd announced on March 19, 2024, that the FDA granted approval for TRYVIO (aprocitentan) to treat pulmonary arterial hypertens...
Madrigal Pharmaceuticals’ FDA approval of RESMETIROM (Resmetirom) for the treatment of non-alcoholic steatohepatitis确立了首个获批用于该适应症的口服疗法,预计将确立公司作为慢性肝病治疗...
BeOne Medicines USA, Inc. received FDA approval on March 13 for TEVIMBRA (tislelizumab), an intravenous immunotherapy, marking a significant expansion...
Advagen Pharma Ltd. announced the March 5 FDA approval of its ANDA207717 for the oral formulation of oxycarbazepine, providing clearance to market the...
BluePoint Laboratories has received marketing authorization from the FDA for its generic version of CAPECITABINE, positioning the firm to capturemarke...
Fresenius Kabi USA has announced FDA approval of tocilizumab (Tyenne, BLA761275) for the treatment of moderate to severe active rheumatoid arthritis, ...
Padagis US LLC announced the FDA approval of its oral lenalidomide ANDA, positioning the company to compete in the generic oncology market where an in...
Kanchan Healthcare Inc. has achieved FDA approval for its ANDA-217782, launching the generic version of oxcarbazepine oral tablets. The move positions...
Macleods Pharmaceuticals Limited has received FDA Approval for its Abbreviated New Drug Application (ANDA207796) for generics of the Hypercholesteremi...
# FDA Approves Generic Isotretinoin ANDA from Aurobindo Pharma Aurobindo Pharma Limited received FDA approval for its generic isotretinoin oral formu...
# FDA Approves Generic Lacosamide from Aurobindo Pharma The U.S. Food and Drug Administration has approved Aurobindo Pharma Limited's generic lacosam...
Zydus Pharmaceuticals USA Inc. received FDA approval for its generic Gabapentin offering under ANDA #203934, positioning the company to capture market...
The FDA has granted approval to Lifestar Pharma LLC’s ANDA for Atropine Sulfate Ophthalmic Solution, a generic alternative to branded versions used fo...
AUROBINDO PHARMA LTD announced a new drug approval today, marking a strategic expansion of its generic portfolio as the company seeks to leverage this...
# FDA Approves Zydus Lifesciences' Intravenous Methylene Blue Formulation Zydus Lifesciences Limited has received FDA approval for its intravenous me...
The FDA has approved Novartis’ NDA218276 for FABHALTA (iptacopan hydrochloride), an oral drug ultimately aiming to disrupt the complement cascade. Thi...
Biocon Pharma Inc. announced the U.S. FDA approval of its Mycophenolic Acid tablets, impacting the competitive landscape by expanding generic options ...
# FDA Approves SpringWorks Therapeutics' OGSIVEO for Dercum Disease Treatment SpringWorks Therapeutics, Inc. received FDA approval for OGSIVEO (nirog...
AstraZeneca announced Friday the FDA granted approval for [Insert Substance Name and Description Here], marking a regulatory milestone that should bol...